Bridgeway Capital Management, LLC Selecta Biosciences Inc Transaction History

Bridgeway Capital Management, LLC

  • $4.76 Billion
  • Q1 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 305,800 shares of SELB stock, worth $256,872. This represents 0.01% of its overall portfolio holdings.

Number of Shares
305,800
Previous 455,800 32.91%
Holding current value
$256,872
Previous $314,000 18.47%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.62 - $0.85 $93,000 - $127,500
-150,000 Reduced 32.91%
305,800 $256,000
Q2 2023

Aug 14, 2023
BUY
$1.04 - $1.4 $21,632 - $29,119
20,800 Added 4.78%
455,800 $510,000
Q1 2023

May 15, 2023
BUY
$1.15 - $1.89 $500,249 - $822,150
435,000 New
435,000 $604,000
Q3 2022

Nov 14, 2022
BUY
$1.33 - $2.6 $25,536 - $49,920
19,200 New
19,200 $31,000
Q2 2020

Aug 14, 2020
SELL
$1.83 - $4.06 $362,523 - $804,285
-198,100 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$1.5 - $4.52 $52,500 - $158,199
-35,000 Reduced 15.02%
198,100 $477,000
Q4 2019

Feb 14, 2020
BUY
$1.32 - $2.47 $217,800 - $407,550
165,000 Added 242.29%
233,100 $555,000
Q2 2019

Aug 14, 2019
BUY
$1.79 - $3.05 $121,899 - $207,705
68,100 New
68,100 $122,000
Q4 2018

Feb 14, 2019
SELL
$2.66 - $15.93 $133,000 - $796,500
-50,000 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$12.07 - $16.0 $301,750 - $400,000
-25,000 Reduced 33.33%
50,000 $778,000
Q1 2018

May 15, 2018
BUY
$8.49 - $11.82 $424,500 - $591,000
50,000 Added 200.0%
75,000 $764,000
Q3 2017

Nov 14, 2017
BUY
$15.22 - $20.03 $380,500 - $500,750
25,000
25,000 $456,000

Others Institutions Holding SELB

# of Institutions
68
Shares Held
41.4M
Call Options Held
16.8K
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email